Riding high on an approval to sell a major new product in the U.S., AtriCure Inc. (NSDQ:ATRC) posted its smallest net loss ever during the second quarter — $764,506, or 5 cents per diluted share.
A consensus of securities analysts surveyed by Thomson Reuters believed the company would lose 12 cents per share during the three months ended June 30.